IRS4 and ovarian carcinoma: Meanwhile, we applied the CRISPR-Cas9 system to genetically knock out the IRS4 gene in those ovarian carcinoma-derived cell lines with high IRS4 expression, such as OVCAR-5 and OVCAR-3.